Prometheus Laboratories Inc

Type: Company
Name: Prometheus Laboratories Inc
Nationality: United States
Web Address: http://www.prometheuslabs.com/
First reported 11 hours ago - Updated 11 hours ago - 1 reports

Examination of Myriad-Mayo Guidance Comments -- BIO Joint Comment

By Donald Zuhn -- On March 4, the U.S. Patent and Trademark Office issued a guidance memorandum, entitled "Guidance For Determining Subject Matter Eligibility Of Claims Reciting Or Involving Laws of Nature, Natural Phenomena, & Natural Products" (or "Myriad-Mayo ... [Published Patent Docs - 11 hours ago]
First reported Oct 21 2014 - Updated Oct 21 2014 - 2 reports

Otonomy Names Yost Chief Commercial Officer

San Diego-based Otonomy Inc., a clinical-stage biopharmaceutical company, announced the appointment of Anthony Yost as chief commercial officer.Yost brings 30 years of experience in pharmaceutical product sales and marketing that includes building and ... [Published San Diego Business Journal - Oct 21 2014]
First reported Oct 20 2014 - Updated Oct 20 2014 - 1 reports

Patients who lost response to vedolizumab achieved disease activity improvement with increased dose frequency

PHILADELPHIA — Marla C. Dubinsky, MD, chief of pediatric gastroenterology and hepatology, and co-director of the Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center, the Icahn School of Medicine at Mt. Sinai Hospital in NY, discusses ... [Published Orthopedics Today - Oct 20 2014]
First reported Oct 16 2014 - Updated Oct 16 2014 - 1 reports

First Final CBM Decision Invalidates Patent Under § 101

U.S. Bancorp v. Retirement Capital Access Management Co.In the first final written decision issued in a Covered Business Method (CBM) proceeding, the Patent Trial and Appeal Board (PTAB, the Board) ruled that it has authority to review petitions premised ... [Published JD Supra - Oct 16 2014]
First reported Oct 16 2014 - Updated Oct 16 2014 - 1 reports

Sherry Knowles Addresses Real World Impact of Myriad-Mayo Guidance at BIO Symposium

By Donald Zuhn -- Last month, at the Biotechnology Industry Organization (BIO) IP & Diagnostics Symposium in Alexandria, VA, Sherry Knowles of Knowles IP Strategies addressed the impact of the U.S. Patent and Trademark Office's Myriad-Mayo Guidance. The ... [Published Patent Docs - Oct 16 2014]
First reported Oct 10 2014 - Updated Oct 11 2014 - 2 reports

'Alice' Casts Ripples Through Courts, Shakes Up Investors

Professor Mark Lemley, Stanford Law SchoolStanford law professor Mark Lemley teaches Introduction to Patent Law in the spring. When his students returned to school this fall, he told them, "Welcome back. Everything's changed since you've been gone."Patent ... [Published Recorder - Oct 11 2014]
First reported Oct 03 2014 - Updated Oct 03 2014 - 1 reports

Appeals Court to Hear BRCA Gene Test Arguments

The U.S. Court of Appeals for the Federal Circuit (CAFC) is expected Monday to hear oral arguments by Myriad Genetics and a rival seeking to market its own breast cancer gene test, more than a year after a mixed ruling by the U.S. Supreme Court invalidated ... [Published Genetic Engineering News - Oct 03 2014]
First reported Oct 01 2014 - Updated Oct 02 2014 - 1 reports

USPTO Outlines Changes to Myriad-Mayo Guidance at BIO Symposium

By Donald Zuhn -- Last Friday, at the Biotechnology Industry Organization (BIO) IP & Diagnostics Symposium in Alexandria, VA, the U.S. Patent and Trademark Office provided additional information regarding changes that the Office plans to make to its controversial ... [Published Patent Docs - Oct 01 2014]
First reported Sep 17 2014 - Updated Sep 18 2014 - 2 reports

The Supreme Court and the tricky issue of software patents

Prior to adjourning for the summer, the United States Supreme Court rendered an opinion relating to the patent eligibility of computer-implemented inventions. In Alice Corp. v. CLS Bank International, the Court held that all claims of a patent owned by ... [Published BizTimes Milwaukee - Sep 18 2014]
First reported Aug 12 2014 - Updated Aug 13 2014 - 2 reports

Stopped at the Threshold: A New Study Reports on PTO Patent Examinations in the wake of Mayo and Myriad

Biotech patent applicants are finding themselves in uncharted waters. After the Supreme Court’s decisions in Mayo Collaborative Svs. v. Prometheus Labs and Ass’n for Molecular Pathology v. Myriad Genetics, companies have been trying to understand ... [Published Patently BIOtech - Aug 12 2014]
First reported Jun 24 2014 - Updated Jun 24 2014 - 2 reports

Patent Parameters

Supreme Court Finds Naturally Occurring DNA to Be Patent Ineligible Last summer, the Supreme Court issued its decision in Association for Molecular Pathology v. Myriad Genetics, Inc., which concerned the patent eligibility of the BRCA1 and BRCA2 genes. ... [Published Patently BIOtech - Jun 24 2014]
First reported Jun 19 2014 - Updated Jun 20 2014 - 2 reports

Supreme Court Issues Decision in Alice Corp. v. CLS Bank

Alice Corp. v. CLS Bank International (2014) By Kevin E. Noonan -- This morning, in Alice Corp. v. CLS Bank, the Supreme affirmed the Federal Circuit's per curiam opinion in CLS Bank v. Alice Corp. in a unanimous opinion by Justice Thomas with a concurring ... [Published Patent Docs - Jun 19 2014]

Quotes

By Donald Zuhn -- On March 4, the U S Patent and Trademark Office issued a guidance memorandum, entitled "Guidance For Determining Subject Matter Eligibility Of Claims Reciting Or Involving Laws of Nature, Natural Phenomena, & Natural Products" (or "Myriad-Mayo Guidance"), to implement a new procedure for determining the subject matter eligibility of claims under 35 U S C § 101 in view of the...
...regulatory filing of the new drug application for AuriPro with the FDA in the first half of 2015," said David Weber, president and CEO of Otonomy. "Tony's expertise in building high-performance commercial teams, and his broad pharmaceutical sales and marketing experience, including products sold in the hospital setting, as well as physician-administered drugs, make him well-suited to lead the commercialization efforts for AuriPro and Otonomy's other product candidates."
...  After the conference, Ms. Knowles told me that she was motivated "to make this unusual personal statement to support all of the brave friends she met in infusion wards fighting for their lives with the only hope coming from news that their doctors will tell them there is a new clinical trial they can try or a new diagnostic that can tell them more about the monster growing inside them."   She also indicated that because of the Myriad and Mayo decisions and the Guidance, and the uncertainty introduced by the decisions and Guidance, ph...
...Court in my view … was quite clear in Mayo , I thought, that you take away the abstract idea, the law of nature," Chief Judge Sharon Prost said. "And then you look at any additional steps to determine whether or not those additional steps were well-understood, routine, conventional."

More Content

All (50) | News (19) | Reports (0) | Blogs (31) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Examination of Myriad-Mayo Guidance Comments --... [Published Patent Docs - 11 hours ago]
Otonomy Names Yost Chief Commercial Officer [Published San Diego Business Journal - Oct 21 2014]
Otonomy Appoints Anthony J. Yost Chief Commerci... [Published Industrial Info Financials - Oct 21 2014]
Patients who lost response to vedolizumab achie... [Published Orthopedics Today - Oct 20 2014]
First Final CBM Decision Invalidates Patent Und... [Published JD Supra - Oct 16 2014]
Sherry Knowles Addresses Real World Impact of M... [Published JD Supra - Oct 16 2014]
Sherry Knowles Addresses Real World Impact of M... [Published Patent Docs - Oct 16 2014]
'Alice' Casts Ripples Through Courts, Shakes Up... [Published Recorder - Oct 11 2014]
The Supreme Court Revisits Patent Eligible Subj... [Published JD Supra - Oct 10 2014]
Appeals Court to Hear BRCA Gene Test Arguments [Published Genetic Engineering News - Oct 03 2014]
USPTO Outlines Changes to Myriad-Mayo Guidance ... [Published JD Supra - Oct 02 2014]
First final CBM decision invalidates patent und... [Published Lexology - Oct 01 2014]
A Trend Toward Earlier Resolution of Patent Eli... [Published Bureau of National Affairs - Oct 01 2014]
USPTO Outlines Changes to Myriad-Mayo Guidance ... [Published Patent Docs - Oct 01 2014]
Myriad set for another round [Published Lexology - Sep 29 2014]
Protecting Big Data Systems in a Post-Alice World [Published JD Supra - Sep 26 2014]
Alice in Wonderland: Are Software Inventions St... [Published JD Supra - Sep 25 2014]
Post-Alice Federal Circuit Finds Software-Relat... [Published Baker & Daniels - Sep 19 2014]
The Supreme Court and the tricky issue of softw... [Published BizTimes Milwaukee - Sep 18 2014]
Supreme Court rules on patentable subject matte... [Published Intellectual Asset Management - Sep 17 2014]
Addressing Section 101 Issues Through Reissue [Published JD Supra - Sep 16 2014]
Be Happy: Software Patents Are Rapidly Disappea... [Published Techdirt - Sep 12 2014]
Judge Bryson: Computerized Loyalty-Point Conver... [Published Patent Law Blog (Patently-O) - Sep 08 2014]
Federal Circuit Falls in Line: Supporting Stron... [Published Patent Law Blog (Patently-O) - Sep 03 2014]
What to do About All These Invalid Patents? [Published Patent Law Blog (Patently-O) - Aug 28 2014]
Examination of Myriad-Mayo Guidance Comments --... [Published Patent Docs - Aug 22 2014]
Stopped at the Threshold: A New Study Reports o... [Published Patently BIOtech - Aug 12 2014]
Stopped at the Threshold: A New Study Reports o... [Published I Am Biotech - Aug 12 2014]
Examination of Myriad-Mayo Guidance Comments --... [Published Patent Docs - Aug 12 2014]
Nodality appoints NLV Partners’ LaPorte as chie... [Published PE Hub Blog - Aug 06 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Examination of Myriad-Mayo Guidance Comments --... [Published Patent Docs - 11 hours ago]
By Donald Zuhn -- On March 4, the U.S. Patent and Trademark Office issued a guidance memorandum, entitled "Guidance For Determining Subject Matter Eligibility Of Claims Reciting Or Involving Laws of Nature, Natural Phenomena, & Natural Products" (or "Myriad-Mayo ...
Sherry Knowles Addresses Real World Impact of M... [Published Patent Docs - Oct 16 2014]
By Donald Zuhn -- Last month, at the Biotechnology Industry Organization (BIO) IP & Diagnostics Symposium in Alexandria, VA, Sherry Knowles of Knowles IP Strategies addressed the impact of the U.S. Patent and Trademark Office's Myriad-Mayo Guidance. The ...
USPTO Outlines Changes to Myriad-Mayo Guidance ... [Published Patent Docs - Oct 01 2014]
By Donald Zuhn -- Last Friday, at the Biotechnology Industry Organization (BIO) IP & Diagnostics Symposium in Alexandria, VA, the U.S. Patent and Trademark Office provided additional information regarding changes that the Office plans to make to its controversial ...
Be Happy: Software Patents Are Rapidly Disappea... [Published Techdirt - Sep 12 2014]
We've written a few times lately about the fact that the Supreme Court's decision in Alice v. CLS Bank seems to have finally broken the dam in getting courts to recognize that most software isn't patentable . We've covered three post-Alice cases where ...
Judge Bryson: Computerized Loyalty-Point Conver... [Published Patent Law Blog (Patently-O) - Sep 08 2014]
Loyalty Conversion Systems v. American Airlines (E.D. Texas 2014)  LoyaltyConversions101Opinion Data processing and business method patents continue to fall like dominoes. In this case, Federal Circuit Judge Bryson – sitting by designation in the Eastern ...
1 2 3 4 5 6 7
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.